EBS
Emergent BioSolutions Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.21
−0.72%Leverage
- Debt / equity
- 1.62x
- Net debt / equity
- 1.06x
- Debt / assets
- 0.51x
- Debt / EBITDA
- -5.24x
- Net debt / EBITDA
- -3.43x
Liquidity & coverage
- Current ratio
- 4.58x
- Quick ratio
- 2.27x
- Cash ratio
- 1.44x
- Interest coverage
- -3.68x
- EBITDA / interest
- -2.71x
- Working capital
- $436.2M
Cash & dividend
- FCF / debt
- 0.31x
- Cash flow / debt
- 0.34x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026